(Q36607266)

15 August 2017

1 reference

title

QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection? (English)

1 reference

15 August 2017

0 references

3

1 reference

15 August 2017

4

1 reference

15 August 2017

Tom G Connell

1

1 reference

15 August 2017

Molebogeng X Rangaka

series ordinal

2

1 reference

15 August 2017

language of work or name

1 reference

1 September 2006

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

15 August 2017

published in

1 reference

15 August 2017

volume

6

1 reference

15 August 2017

issue

5

1 reference

15 August 2017

page(s)

663-677

1 reference

The TB epidemic from 1992 to 2002.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Resurgence of paediatric tuberculosis in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

The challenge of diagnosing tuberculosis in children: a perspective from a high incidence area

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Clinical practice. Latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Tuberculosis and HIV/AIDS: epidemiological and clinical aspects (world perspective).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Diagnosis of tuberculosis in children: increased need for better methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Diagnosis and treatment of tuberculosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Specific immune-based diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Evolution and current use of the tuberculin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Serial testing of health care workers for tuberculosis using interferon-gamma assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Early detection of perinatal tuberculosis using a whole blood interferon-gamma release assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Posttransplant Mycobacterium tuberculosis disease following liver transplantation and the need for cautious evaluation of Quantiferon TB GOLD results in the transplant setting: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Direct costs of three models for the screening of latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Repeated tuberculin testing does not induce false positive ELISPOT results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Transmission of Mycobacterium tuberculosis undetected by tuberculin skin testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Integrating tuberculosis and HIV care in the primary care setting in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

Cost-optimisation of screening for latent tuberculosis in close contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.6.5.663

21 January 2018

Identifiers

DOI

10.1586/14737159.6.5.663

1 reference

15 August 2017

1 reference